Multiple sclerosis (MS) affects nearly 2.8 million people worldwide, with rising prevalence in both developed and developing nations (National MS Society). This chronic disease targets the central nervous system, disrupting communication between the brain and body. The impact of MS varies significantly, leading to physical, cognitive, and emotional challenges. One major hurdle in effectively managing MS is the complexity of treatment decisions, which are often compounded by late detection and the unpredictable course of the disease (World Health Organization).
Health
2. Injectable Treatments Injectable treatments have been foundational in MS care for decades. These medications, such as interferon beta (e.g., Avonex, Rebif) and glatiramer acetate (Copaxone),…